| Financial Year |
March 31 2023 |
| Monetary Funds |
190,521,972.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
120,769,427.02 |
| Accounts Receivable |
581,283,397.60 |
| Advances to Suppliers |
118,058,524.40 |
| Other Receivables |
2,843,035.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
728,252,191.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,721,299.89 |
| Total Current Assets |
1,918,953,333.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
751,136,440.57 |
| Under-construction Projects |
360,120,567.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,449,587.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
60,949,780.32 |
| Deferred Income Tax Assets |
2,645,484.13 |
| Other Non-Current Assets |
176,850,068.97 |
| Sub-Total of Non-Current Assets |
1,451,441,122.67 |
| Total Assets |
3,370,394,455.83 |
| Short-Term Loans |
493,200,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
434,468,706.86 |
| Accounts Payable |
768,126,741.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,720,756.09 |
| Taxes Payable |
3,419,367.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,289,510.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,646,288.50 |
| Other Current Liabilities |
89,101,311.75 |
| Sub-Total of Current Liabilities |
1,984,863,264.78 |
| Long-term Loans |
40,065,833.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,410,054.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
76,161,710.98 |
| Total Liabilities |
2,061,024,975.76 |
| Paid-In Capital(Or Share Stock) |
154,905,300.00 |
| Capital Surplus |
518,163,599.89 |
| Surplus Reserve |
58,190,484.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
578,110,095.51 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,309,369,480.07 |
| Owner's Equity（Stockholder's Equity） |
1,309,369,480.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,370,394,455.83 |
